Orbis Holdings’s AbbVie ABBV Stock Holding History

Orbis Holdings’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$256M	Buy	4,325,646 +2,425,931	+128%	+$140M	2.01%	14
2015 Q3	$103M	Sell	1,899,715 -355,764	-16%	-$23.2M	0.88%	31
2015 Q2	$152M	Buy	2,255,479 +1,324,086	+142%	+$86.4M	1.15%	25
2015 Q1	$54.5M	Buy	+931,393	New	+$56.3M	0.44%	42

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Orbis Holdings's ABBV Position: Q4 2015 in Review

Orbis Holdings increased its AbbVie (ABBV) stake by 128% in Q4 2015, buying an estimated $140M and bringing the position to 4,325,646 shares worth $256M. The position accounts for 2.01% of the portfolio, ranked #14.

Orbis Holdings first reported a position in ABBV in Q1 2015 and has held it in 4 quarters since. 1,637 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

Orbis Holdings held 4,325,646 shares of AbbVie worth $256M as of Q4 2015.
Orbis Holdings bought 2,425,931 AbbVie shares in Q4 2015, an estimated $140M.
AbbVie made up 2.01% of Orbis Holdings's portfolio in Q4 2015, its #14 holding.
Orbis Holdings first reported a position in AbbVie in Q1 2015 and has held it in 4 quarters since.
1,637 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on Orbis Holdings's 13F filing for Q4 2015, filed 16 Feb 2016.